Temat: "Cisplatin" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer.
Autorzy :: Sun Z; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Xu S; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Cai Q; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Zhou W; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Jiao X; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Bao M; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China.
Yu X; Department of Nephrology, Zhongshan Hospital, Fudan University, China; Shanghai Medical Center for Kidney, China; Shanghai Key Laboratory of Kidney and Blood Purifcation, China; Shanghai Institute of Kidney and Dialysis, Shanghai, China. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2020 Dec 15; Vol. 263, pp. 118672. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents/*toxicity
Cisplatin/*toxicity
Indoles/*pharmacology
Kidney Diseases/*prevention & control
Ovarian Neoplasms/*drug therapy
Oximes/*pharmacology
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Cell Line ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cisplatin/pharmacology ; Female ; Humans ; Kidney Diseases/chemically induced ; Kidney Tubules, Proximal/drug effects ; Kidney Tubules, Proximal/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Nude ; Oxidative Stress/drug effects ; Wnt Signaling Pathway/drug effects ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: The protective efficacy of vitamin E and cod liver oil against cisplatin-induced acute kidney injury in rats.
Autorzy :: Abo-Elmaaty AMA; Department of Pharmacology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44511, Egypt.
Behairy A; Department of Physiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44511, Egypt.
El-Naseery NI; Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, 44511, Egypt.
Abdel-Daim MM; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia. .; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt. .; Pokaż więcej
Źródło :: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2020 Dec; Vol. 27 (35), pp. 44412-44426. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji :: Journal Article
MeSH Terms :: Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/drug therapy
Acute Kidney Injury*/prevention & control
Cisplatin*/toxicity
Animals ; Antioxidants/metabolism ; Cod Liver Oil/metabolism ; Kidney/metabolism ; Male ; Oxidative Stress ; Rats ; Rats, Wistar ; Superoxide Dismutase/metabolism ; Vitamin E/metabolism ; Vitamin E/pharmacology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance.
Autorzy :: Li D; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Cui R; Department of Medical Oncology, Tianjin Union Medical Center, Tianjin, China.
Xu S; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
Liu Y; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.; Pokaż więcej
Źródło :: Drug delivery [Drug Deliv] 2020 Dec; Vol. 27 (1), pp. 191-199.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Nanoparticles/*chemistry
Oleanolic Acid/*pharmacology
Animals ; Antineoplastic Agents/administration & dosage ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Survival/drug effects ; Cisplatin/administration & dosage ; Drug Combinations ; Drug Liberation ; Drug Resistance, Multiple/drug effects ; Drug Stability ; Hydrogen-Ion Concentration ; Male ; Mice ; Mice, Inbred BALB C ; Oleanolic Acid/administration & dosage ; Particle Size
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Protective effects of Citrus limonia oil against cisplatin-induced nephrotoxicity.
Autorzy :: Abdel-Daim MM; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia. .; Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, 41522, Egypt. .
Mahmoud OM; Anatomy and Embryology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Al Badawi MH; Anatomy and Embryology Department, Faculty of Medicine, Helwan University, Helwan, Egypt.
Alghamdi J; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Alkahtani S; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Salem NA; Anatomy and Embryology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.; Pokaż więcej
Źródło :: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2020 Nov; Vol. 27 (33), pp. 41540-41550. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :: Journal Article
MeSH Terms :: Cisplatin*/toxicity
Citrus*
Animals ; Antioxidants/metabolism ; Creatinine/metabolism ; Kidney/metabolism ; Male ; Mice ; Oxidative Stress
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis.
Autorzy :: Sun YU; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Nishino H; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Sugisawa N; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Yamamoto J; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Hamada K; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Zhu G; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Lim HI; AntiCancer, Inc., San Diego, CA, U.S.A.; Department of Surgery, University of California, San Diego, CA, U.S.A.
Hoffman RM; AntiCancer, Inc., San Diego, CA, U.S.A. .; Department of Surgery, University of California, San Diego, CA, U.S.A.; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2020 Nov; Vol. 40 (11), pp. 6083-6091.
Typ publikacji :: Journal Article
MeSH Terms :: Xenograft Model Antitumor Assays*
Carbon-Sulfur Lyases/*therapeutic use
Cisplatin/*therapeutic use
Recombinant Proteins/*therapeutic use
Urinary Bladder Neoplasms/*drug therapy
Urinary Bladder Neoplasms/*pathology
Administration, Oral ; Animals ; Carbon-Sulfur Lyases/administration & dosage ; Carbon-Sulfur Lyases/pharmacology ; Cell Proliferation/drug effects ; Cisplatin/administration & dosage ; Cisplatin/pharmacology ; Dose-Response Relationship, Drug ; Female ; Humans ; Mice, Nude ; Neoplasm Metastasis ; Recombinant Proteins/administration & dosage ; Recombinant Proteins/pharmacology ; Tumor Burden/drug effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
Autorzy :: Hase T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan. .
Miyazaki M; Department of Pharmacy, Nagoya University Hospital, Nagoya, Japan.
Ichikawa K; Department of Pharmacy, Nagoya University Hospital, Nagoya, Japan.
Yogo N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ozawa N; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hatta T; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ando M; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Sato M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kondo M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
Yamada K; Department of Pharmacy, Nagoya University Hospital, Nagoya, Japan.
Hasegawa Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.; National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.; Pokaż więcej
Źródło :: International journal of clinical oncology [Int J Clin Oncol] 2020 Nov; Vol. 25 (11), pp. 1928-1935. Date of Electronic Publication: 2020 Aug 01.
Typ publikacji :: Clinical Trial; Journal Article
MeSH Terms :: Antineoplastic Agents/*adverse effects
Cisplatin/*adverse effects
Kidney Diseases/*prevention & control
Lung Neoplasms/*drug therapy
Magnesium/*therapeutic use
Adult ; Aged ; Antiemetics/therapeutic use ; Antineoplastic Agents/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cisplatin/administration & dosage ; Creatinine/analysis ; Dietary Supplements ; Female ; Humans ; Kidney Diseases/chemically induced ; Kidney Function Tests ; Magnesium/administration & dosage ; Magnesium/blood ; Male ; Middle Aged ; Palonosetron/therapeutic use ; Prospective Studies ; Protective Agents/therapeutic use ; Renal Insufficiency/etiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Oral metronomic therapy in head and neck cancer.
Autorzy :: Pramanik R; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi 110 029, India. Electronic address: .
Sharma A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi 110 029, India.
Kumar A; Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi 110 029, India.; Pokaż więcej
Źródło :: The Lancet. Global health [Lancet Glob Health] 2021 Jan; Vol. 9 (1), pp. e19.
Typ publikacji :: Letter; Comment
MeSH Terms :: Cisplatin*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Administration, Intravenous ; Humans ; Neoplasm Recurrence, Local
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Oral metronomic therapy in head and neck cancer.
Autorzy :: Sharma V; Department of Medical Oncology, National Cancer Institute, Jhajjar 124105, India. Electronic address: .
Kumar A; Department of Medical Oncology, National Cancer Institute, Jhajjar 124105, India.; Pokaż więcej
Źródło :: The Lancet. Global health [Lancet Glob Health] 2021 Jan; Vol. 9 (1), pp. e20.
Typ publikacji :: Letter; Comment
MeSH Terms :: Cisplatin*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Administration, Intravenous ; Humans ; Neoplasm Recurrence, Local
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Oral metronomic therapy in head and neck cancer - Authors' reply.
Autorzy :: Patil V; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
Noronha V; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
Joshi A; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
Menon N; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
Banavali S; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India.
Prabhash K; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai 400012, India. Electronic address: .; Pokaż więcej
Źródło :: The Lancet. Global health [Lancet Glob Health] 2021 Jan; Vol. 9 (1), pp. e21.
Typ publikacji :: Letter; Comment
MeSH Terms :: Cisplatin*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Administration, Intravenous ; Humans ; Neoplasm Recurrence, Local
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Efficacy of intravenous NEPA, a fixed NK 1 /5-HT 3 receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin- and anthracycline cyclophosphamide (AC)-based chemotherapy: A review of phase 3 studies.
Autorzy :: Aapro M; Genolier Cancer Center, Clinique de Genolier, Case Postale 100, Route du Muids, Genolier, Switzerland. Electronic address: .
Navari RM; Division of Hematology/Oncology, North Pavillion 2540K, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States.
Roeland E; Oncology & Palliative Care, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, Massachusetts, United States.
Zhang L; Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou City, Guangdong Province, China.
Schwartzberg L; Hematology & Oncology, West Cancer Center & Research Institute, 7945 Wolf River Boulevard, Germantown, Tennessee, United States.; Pokaż więcej
Źródło :: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2021 Jan; Vol. 157, pp. 103143. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antiemetics*
Cisplatin*/adverse effects
Adult ; Anthracyclines ; Cyclophosphamide/adverse effects ; Double-Blind Method ; Humans ; Nausea/chemically induced ; Nausea/drug therapy ; Nausea/prevention & control ; Serotonin ; Vomiting/prevention & control
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: [A Case of Gallbladder Cancer with Para-Aortic Lymph Node Metastasis Successfully Treated by Gemcitabine plus Cisplatin Combination Chemotherapy and Conversion Surgery].
Autorzy :: Kato T; Dept. of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences.
Matsuo Y
Ueda G
Aoyama Y
Omi K
Hayashi Y
Imafuji H
Saito K
Tsuboi K
Morimoto M
Ogawa R
Takahashi H
Naitoh I
Hayashi K
Takiguchi S; Pokaż więcej
Źródło :: Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 Dec; Vol. 47 (13), pp. 2204-2206.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Cisplatin*/therapeutic use
Gallbladder Neoplasms*/drug therapy
Gallbladder Neoplasms*/surgery
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Deoxycytidine/analogs & derivatives ; Female ; Humans ; Lymph Nodes ; Lymphatic Metastasis ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway.
Autorzy :: Cao WQ; School of Life Sciences, Jilin University, Changchun, China.; Department of Biotechnology, Zhuhai Hopegenes Medical & Phamaceutical Institute, Zhuhai, China.
Zhai XQ; Department of Pathology, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Ma JW; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Fu XQ; School of Life Sciences, Jilin University, Changchun, China.
Zhao BS; Department of Biotechnology, Zhuhai Hopegenes Medical & Phamaceutical Institute, Zhuhai, China.
Zhang P; Department of Cardiology, The Central Hospital of Taian, Taian, China.
Fu XY; School of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, China.; Pokaż więcej
Źródło :: Pharmaceutical biology [Pharm Biol] 2020 Dec; Vol. 58 (1), pp. 72-79.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents/*pharmacology
Camphanes/*pharmacology
Cisplatin/*pharmacology
Glioma/*drug therapy
Antineoplastic Agents/administration & dosage ; Apoptosis/drug effects ; Camphanes/administration & dosage ; Cell Line, Tumor ; Cell Survival/drug effects ; Cisplatin/administration & dosage ; DNA Damage/drug effects ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Glioma/pathology ; Humans ; Oxidative Stress/drug effects ; Phosphatidylinositol 3-Kinase/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Reactive Oxygen Species/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Ultrasound targeting of microbubble-bound anti PD-L1 mAb to enhance anti-tumor effect of cisplatin in cervical cancer xenografts treatment.
Autorzy :: Ma Y; Medical College of China Three Gorges University, Yichang, China; Department of Ultrasonography, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, China.
Han J; Medical College of China Three Gorges University, Yichang, China.
Jiang J; Medical College of China Three Gorges University, Yichang, China.
Zheng Z; Medical College of China Three Gorges University, Yichang, China.
Tan Y; Medical College of China Three Gorges University, Yichang, China.
Liu C; Medical College of China Three Gorges University, Yichang, China; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, Yichang, China. Electronic address: .
Zhao Y; Medical College of China Three Gorges University, Yichang, China. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2020 Dec 01; Vol. 262, pp. 118565. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :: Journal Article
MeSH Terms :: Microbubbles*
Antibodies, Monoclonal/*administration & dosage
B7-H1 Antigen/*immunology
Cisplatin/*pharmacology
Uterine Cervical Neoplasms/*drug therapy
Animals ; Antibodies, Monoclonal/immunology ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacology ; CD8-Positive T-Lymphocytes/metabolism ; Cell Line, Tumor ; Cisplatin/administration & dosage ; Cytokines/metabolism ; Female ; Humans ; Lipids/chemistry ; Mice ; Mice, Inbred BALB C ; Ultrasonography ; Uterine Cervical Neoplasms/pathology ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription.
Autorzy :: Liu Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Wang X; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Li W; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Xu Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhuo Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Li M; Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
He Y; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Wang X; Biomedical Informatics Research Lab, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Guo Q; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Zhao L; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. .
Qiang L; State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. .; Pokaż więcej
Źródło :: Oncogene [Oncogene] 2020 Nov; Vol. 39 (45), pp. 6893-6905. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Carcinoma, Non-Small-Cell Lung/*drug therapy
Cisplatin/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Flavonoids/*pharmacology
Lung Neoplasms/*drug therapy
Animals ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Apoptosis/drug effects ; Apoptosis/genetics ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Hypoxia/genetics ; Cell Line, Tumor ; Cisplatin/therapeutic use ; DNA Repair/drug effects ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Drug Synergism ; Flavonoids/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Mice ; Promoter Regions, Genetic ; Transcription, Genetic/drug effects ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: An imbalance in competing mortality favouring Debio 1143.
Autorzy :: Zakeri K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: .
Yu Y; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. e502.
Typ publikacji :: Letter; Comment
MeSH Terms :: Cisplatin*
Head and Neck Neoplasms*
Chemoradiotherapy ; Double-Blind Method ; Humans ; Squamous Cell Carcinoma of Head and Neck
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: An imbalance in competing mortality favouring Debio 1143 - Authors' reply.
Autorzy :: Bourhis J; CHUV, Service de Radiooncologie, Bâtiment Hospitalier, 1011 Lausanne, Switzerland. Electronic address: .
Sun XS; Department of Radiation Oncology, Nord Franche-Comté de Montbéliard and CHRU de Besançon, Besançon, France.
Tao Y; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France.; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Nov; Vol. 21 (11), pp. e503.
Typ publikacji :: Letter; Comment
MeSH Terms :: Cisplatin*
Head and Neck Neoplasms*
Chemoradiotherapy ; Double-Blind Method ; Humans ; Squamous Cell Carcinoma of Head and Neck
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
Autorzy :: Ashrafzadeh MS; Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Akbarzadeh A; Department of Pilot Nanobiotechnology, Pasteur Institute of Iran, Tehran, Iran.
Heydarinasab A; Department of Chemical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Ardjmand M; Department of Chemical Engineering, South Tehran Branch, Islamic Azad University, Tehran, Iran.; Pokaż więcej
Źródło :: International journal of nanomedicine [Int J Nanomedicine] 2020 Sep 23; Vol. 15, pp. 7035-7049. Date of Electronic Publication: 2020 Sep 23 (Print Publication: 2020).
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents/*administration & dosage
Brain Neoplasms/*drug therapy
Cisplatin/*administration & dosage
Glioblastoma/*drug therapy
Liposomes/*administration & dosage
Animals ; Antibodies, Monoclonal/chemistry ; Antineoplastic Agents/pharmacokinetics ; Antineoplastic Agents/pharmacology ; Blood Urea Nitrogen ; Blood-Brain Barrier/drug effects ; Brain Neoplasms/mortality ; Brain Neoplasms/pathology ; Cisplatin/pharmacokinetics ; Cisplatin/pharmacology ; Drug Delivery Systems/methods ; Drug Liberation ; Dynamic Light Scattering ; Enzymes/metabolism ; Glioblastoma/mortality ; Glioblastoma/pathology ; Liposomes/chemistry ; Liposomes/pharmacokinetics ; Male ; Nanoparticles/chemistry ; Rats, Wistar ; Receptors, Transferrin/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.
Autorzy :: de Vries G; Department of Medical Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Rosas-Plaza X; Department of Medical Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van Vugt MATM; Department of Medical Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Gietema JA; Department of Medical Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
de Jong S; Department of Medical Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: .; Pokaż więcej
Źródło :: Cancer treatment reviews [Cancer Treat Rev] 2020 Aug; Vol. 88, pp. 102054. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cisplatin/*pharmacology
Testicular Neoplasms/*drug therapy
Animals ; Cisplatin/administration & dosage ; Drug Resistance, Neoplasm ; Humans ; Male ; Molecular Targeted Therapy ; Neoplasms, Germ Cell and Embryonal/drug therapy ; Randomized Controlled Trials as Topic
SCR Disease Name :: Testicular Germ Cell Tumor
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
Autorzy :: Songyang Y; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, China.
Song T; Department of Immunology, School of Basic Medical Science, Wuhan University, Wuhan, China.
Shi Z; Human Biology Program, University of Toronto, ON M5S 3J6, Canada.
Li W; Renmin Hospital of Wuhan University, Department of Emergency, Wuhan, China.
Yang S; College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, China.
Li D; Department of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, China. Electronic address: .; Pokaż więcej
Źródło :: Gene [Gene] 2021 Feb 05; Vol. 768, pp. 145309. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*drug therapy
Cisplatin/*administration & dosage
Lung Neoplasms/*drug therapy
Vitamin D/*administration & dosage
A549 Cells ; Animals ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cisplatin/pharmacology ; Drug Resistance, Neoplasm/drug effects ; Drug Synergism ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Lung Neoplasms/metabolism ; Mice ; Mice, Nude ; Phosphatidylinositol 3-Kinases/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects ; Vitamin D/pharmacology ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Toxicity, risk factors and management of cisplatin-induced toxicity: A prospective study.
Autorzy :: Ben Ayed W; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.
Ben Said A; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Pharmacy of Monastir, Monastir, Tunisia.
Hamdi A; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Pharmacy of Monastir, Monastir, Tunisia.
Mokrani A; Department of Oncology, Salah Azaiez Institute, Tunis, Tunisia.
Masmoudi Y; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.
Toukabri I; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.
Limayem I; Department of Pharmacy, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Pharmacy of Monastir, Monastir, Tunisia.
Yahyaoui Y; Department of Oncology, Salah Azaiez Institute, Tunis, Tunisia.; Pokaż więcej
Źródło :: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Oct; Vol. 26 (7), pp. 1621-1629. Date of Electronic Publication: 2020 Feb 11.
Typ publikacji :: Journal Article
MeSH Terms :: Antineoplastic Agents/*adverse effects
Cisplatin/*adverse effects
Neoplasms/*drug therapy
Adult ; Aged ; Cisplatin/administration & dosage ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Risk Factors
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cisplatin"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język